GTX-758

Generic Name
GTX-758
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C19H13F2NO3
CAS Number
938067-78-8
Unique Ingredient Identifier
406GR1485Z
Background

GTX-758 is under investigation in clinical trial NCT01420861 (GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer).

Associated Conditions
-
Associated Therapies
-

GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2011-08-22
Last Posted Date
2023-10-06
Lead Sponsor
GTx
Target Recruit Count
18
Registration Number
NCT01420861
Locations
🇺🇸

GTx Investigative Site, Virginia Beach, Virginia, United States

🇺🇸

GTx Investigational Site, Jeffersonville, Indiana, United States

Phase II, Dose Finding Study of GTx-758

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2011-07-13
Last Posted Date
2024-04-22
Lead Sponsor
GTx
Target Recruit Count
77
Registration Number
NCT01393119
Locations
🇺🇸

GTx Investigative Site, Bala-Cynwyd, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath